To further examine the pharmacological effects of ITC-6102RO in vivo, IHC staining of JIMT-1 tumor tissues was performed using antibodies against cleaved-caspase-3 (apoptosis), gamma-H2AX (DNA damage), and cyclin E (S phase checkpoint). The gene discussed is CASP3; the disease is neoplasm.